Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

COVID-19 is a critical pandemic that affected communities around the world, and there is currently no specific drug treatment for it. The virus enters the human cells via spikes and induces cytokine production and finally arrests the cell cycle. Ivermectin shows therapeutic potential for treating COVID-19 infection based on in vitro studies. Docking studies have shown a strong affinity between Ivermectin and some virulence factors of COVID-19. Notably, clinical evidence has demonstrated that Ivermectin with usual doses is effective by both the prophylactic and therapeutic approaches in all phases of the disease. Ivermectin inhibits both the adhesion and replication of the virus. Local therapy of the lung with Ivermectin or combination therapy may get better results and decrease the dose of the drug.


Nastaran Barati, Seyedmousa Motavallihaghi, Banafsheh Nikfar, Shahla Chaichian, Amir Abbas Momtazi-Borojeni. Potential therapeutic effects of Ivermectin in COVID-19. Experimental biology and medicine (Maywood, N.J.). 2022 Aug;247(15):1388-1396

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 35686662

View Full Text